meglumine antimoniate has been researched along with Cardiomyopathy, Dilated in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aounallah, A; Belajouza, C; Denguezli, M; Lahouel, M; Manaa, L; Mkhinini, H; Salah, NB | 1 |
1 other study(ies) available for meglumine antimoniate and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Systemic meglumine antimoniate-induced severe dilated cardiomyopathy.
Topics: Antiprotozoal Agents; Cardiomyopathy, Dilated; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2022 |